Maryland Academy of Advanced Practice Clinicians

Register now for Pharmacology Update 2020: Webinar & Kick-off Zoom Meeting. Why? An expert’s opinion on acute ischemic stroke pharmacotherapy

Posted about 1 month ago by Elaine Crain

Michael Armahizer is a Clinical Specialist in the Neurocritical Care Unit at the University of Maryland Medical Center. He also serves as the PGY-1 Pharmacy Practice Residency Coordinator at the University of Maryland Medical Center. In his capacity as the clinical pharmacist in the Neurocritical Care unit, he routinely works with the multidisciplinary care team managing patients presenting with acute ischemic stroke and has been involved in the development of guidelines and recommendations for the management of these patients within the health system.

Dr. Armahizer received a Doctorate of Pharmacy Degree from Duquesne University. He completed ASHP-accredited PGY-1 Pharmacy Practice and PGY-2 Critical Care Residencies at the University of Pittsburgh Medical Center and the University of Pittsburgh School of Pharmacy. He has practiced in Cardiothoracic Surgery and Neurocritical Care. His research interests include medication safety in neurologically injured patients, drug disposition of anti-epileptic drugs in patients receiving continuous renal replacement therapy, and safe and appropriate antimicrobial therapy utilization.


Don't forget to register for our October 3rd Zoom Kickoff meeting at 10am EST -attending the meeting is free but please add the Attend Kickoff meeting option when registering

Registration is open and the webinar will go live on October 3, 2020

This education activity has been submitted to the American Association of Nurse Practitioners for approval of 7.0 contact hours of continuing education (which includes 6.6 hours pharmacology).


We also offer 16 additional CEs with a focus on pharmacology at

Join MAAPC or CBANACNS and save $112 ($8 per CE)

Questions? Contact Lorraine Diana & Gena Stanek at